Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
2002 12
2003 18
2004 22
2005 19
2006 22
2007 17
2008 23
2009 23
2010 23
2011 25
2012 21
2013 31
2014 20
2015 34
2016 38
2017 49
2018 54
2019 58
2020 75
2021 98
2022 84
2023 81
2024 23

Text availability

Article attribute

Article type

Publication date

Search Results

755 results

Results by year

Filters applied: . Clear all
Page 1
ENSEMBLE PLUS: final results of shorter ocrelizumab infusion from a randomized controlled trial.
Hartung HP, Berger T, Bermel RA, Brochet B, Carroll WM, Holmøy T, Karabudak R, Killestein J, Nos C, Patti F, Perrin Ross A, Vanopdenbosch L, Vollmer T, Buffels R, Garas M, Kadner K, Manfrini M, Wang Q, Freedman MS. Hartung HP, et al. Among authors: berger t. J Neurol. 2024 Apr 22. doi: 10.1007/s00415-024-12326-z. Online ahead of print. J Neurol. 2024. PMID: 38649522
Managing multiple sclerosis in individuals aged 55 and above: a comprehensive review.
Fernández Ó, Sörensen PS, Comi G, Vermersch P, Hartung HP, Leocani L, Berger T, Van Wijmeersch B, Oreja-Guevara C. Fernández Ó, et al. Among authors: berger t. Front Immunol. 2024 Apr 5;15:1379538. doi: 10.3389/fimmu.2024.1379538. eCollection 2024. Front Immunol. 2024. PMID: 38646534 Free PMC article. Review.
Consensus quality indicators for monitoring multiple sclerosis.
Voigt I, Fischer S, Proschmann U, Konofalska U, Richter P, Schlieter H, Berger T, Meuth SG, Hartung HP, Akgün K, Ziemssen T. Voigt I, et al. Among authors: berger t. Lancet Reg Health Eur. 2024 Mar 29;40:100891. doi: 10.1016/j.lanepe.2024.100891. eCollection 2024 May. Lancet Reg Health Eur. 2024. PMID: 38585674 Free PMC article. Review.
General neurology: Current challenges and future implications.
Bassetti CLA, Accorroni A, Arnesen A, Basri HB, Berger T, Berlit P, Boon P, Charway-Felli A, Kruja J, Lewis S, Markowski M, Medina MT, McCombe P, Moro E, Ozturk S, Smith P, Vuletic V. Bassetti CLA, et al. Among authors: berger t. Eur J Neurol. 2024 Mar 28:e16237. doi: 10.1111/ene.16237. Online ahead of print. Eur J Neurol. 2024. PMID: 38545838 Free article.
Olfactory threshold as a biomarker of long-term relapse activity in multiple sclerosis.
Berek K, Hegen H, Auer M, Barket R, Di Pauli F, Hocher J, Krajnc N, Zinganell A, Deisenhammer F, Berger T, Bsteh G. Berek K, et al. Among authors: berger t. Mult Scler Relat Disord. 2024 Mar 11;85:105545. doi: 10.1016/j.msard.2024.105545. Online ahead of print. Mult Scler Relat Disord. 2024. PMID: 38479044 Free article.
Sex impacts treatment decisions in multiple sclerosis.
Hegen H, Berek K, Deisenhammer F, Berger T, Enzinger C, Guger M, Kraus J, Walde J, Di Pauli F. Hegen H, et al. Among authors: berger t. J Neurol. 2024 Mar 5. doi: 10.1007/s00415-024-12270-y. Online ahead of print. J Neurol. 2024. PMID: 38441611
755 results